Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey

MLA

Maurizio Cardi, et al. “Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey.” Frontiers in Oncology, vol. 12, May 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.822550.

APA

Maurizio Cardi, Marc Pocard, Rea Lo Dico, Gianmaria Fiorentini, Mario Valle, Roberta Gelmini, Marco Vaira, Enrico Maria Pasqual, Salvatore Asero, Gianluca Baiocchi, Andrea Di Giorgio, Alessandra Spagnoli, Francesco Di Marzo, Bianca Sollazzo, Giuseppe D’Ermo, Daniele Biacchi, Franco Iafrate, & Paolo Sammartino. (2022). Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.822550

Chicago

Maurizio Cardi, Marc Pocard, Rea Lo Dico, Gianmaria Fiorentini, Mario Valle, Roberta Gelmini, Marco Vaira, et al. 2022. “Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey.” Frontiers in Oncology 12 (May). doi:10.3389/fonc.2022.822550.